Analyst Ratings for ABVC BioPharma, Inc. (ABVC)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/16/2022 | Maxim Group | Jason McCarthy | Downgrade | Hold (Buy) |
N/A (N/A) |
0.72 (1.34) |
86.11% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/16/2022 | Maxim Group | Jason McCarthy | Downgrade | Hold (Buy) |
N/A (N/A) |
0.72 (1.34) |
86.11% | Details |